Adaptive Biotechnologies | 4: Statement of changes in beneficial ownership of securities-Officer PISKEL KYLE
Adaptive Biotechnologies | SC 13G: Statement of acquisition of beneficial ownership by individuals-Rubric Capital Management LP(9.76%),David Rosen(9.76%)
Adaptive Biotechnologies | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Matrix Capital Management Company LP(0.44%),David E. Goel(0.44%)
Adaptive Biotechnologies | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-The Vanguard Group(7.21%)
Adaptive Biotechnologies | SC 13G: Statement of acquisition of beneficial ownership by individuals-Nikko Asset Management Americas, Inc.(5.24%)
Adaptive Biotechnologies | SC 13G: Statement of acquisition of beneficial ownership by individuals-Sumitomo Mitsui Trust Group, Inc. (“SMTG”)(5.24%),Nikko Asset Management Co., Ltd. (“NAM”)(5.24%)
Adaptive Biotechnologies | SC 13G: Statement of acquisition of beneficial ownership by individuals-The Vanguard Group(7.21%)
Adaptive Biotechnologies | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Millennium Management LLC(6.4%),Millennium Group Management LLC(6.4%), etc.
Adaptive Biotechnologies | 4: Statement of changes in beneficial ownership of securities-Officer BOBULSKY SUSAN
Adaptive Biotechnologies | 4: Statement of changes in beneficial ownership of securities-Officer Taylor Stacy L
Adaptive Biotechnologies | SC 13G: Statement of acquisition of beneficial ownership by individuals-Millennium Management LLC(5.3%),Millennium Group Management LLC(5.3%), etc.
Adaptive Biotechnologies | 4: Statement of changes in beneficial ownership of securities-Officer PISKEL KYLE
Adaptive Biotechnologies | 4: Statement of changes in beneficial ownership of securities-Director NEUPERT PETER M
Adaptive Biotechnologies | 4: Statement of changes in beneficial ownership of securities-Director Pellini Michael J
Adaptive Biotechnologies | 4: Statement of changes in beneficial ownership of securities-Director OWEN KATEY EINTERZ
Adaptive Biotechnologies | 4: Statement of changes in beneficial ownership of securities-Director NEUPERT PETER M
Adaptive Biotechnologies | 4: Statement of changes in beneficial ownership of securities-Director HERSHBERG ROBERT
Adaptive Biotechnologies | 4: Statement of changes in beneficial ownership of securities-Director GRIFFIN MICHELLE RENEE
Adaptive Biotechnologies | 4: Statement of changes in beneficial ownership of securities-Officer PISKEL KYLE
Adaptive Biotechnologies | 4: Statement of changes in beneficial ownership of securities-Officer Taylor Stacy L
No Data